A Study of Mavrilimumab in Subjects With Moderate-to-Severe Rheumatoid Arthritis

Clinical trial NCT01706926 · COMPLETED

Trial details

NCT number: NCT01706926
Sponsor: MedImmune LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2012-08-01
Primary completion: 2013-12-01
Enrollment: 420

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.